Cargando…

Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y(12) receptor inhibitor in patients undergoing percutaneous coronary intervention (PCI) reduces the risk of ischemic events but reduces the risk of ischemic events but increases the risk of bleeding, which in turn is associated with increased mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pelliccia, Francesco, Gragnano, Felice, Pasceri, Vincenzo, Cesaro, Arturo, Zimarino, Marco, Calabrò, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267626/ https://www.ncbi.nlm.nih.gov/pubmed/35806860 http://dx.doi.org/10.3390/jcm11133574

Ejemplares similares

Multimodality evaluation of cardiac injury in COVID-19: Getting to the heart of the matter()
por: Gragnano, Felice, et al.
Publicado: (2021)

Dual Antiplatelet Therapy and the Severity Risk of Lower Intestinal Bleeding
por: Carlin, Neal, et al.
Publicado: (2017)

Risk of bleeding in patients with continued dual antiplatelet therapy during orthopedic surgery
por: Hu, San-Bao, et al.
Publicado: (2019)

Performance of PRECISE-DAPT and Age–Bleeding–Organ Dysfunction Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy in Chinese Elderly Patients
por: Dong, Liang, et al.
Publicado: (2022)

The stent in the high-bleeding risk patient: antiplatelet monotherapy?
por: Capranzano, Piera
Publicado: (2022)

One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
por: Kandzari, David E., et al.
Publicado: (2020)

Dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk: A systematic review and meta-analysis
por: Han, Yan, et al.
Publicado: (2023)

The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery
por: Nardi, Paolo, et al.
Publicado: (2021)

Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis
por: Bainey, Kevin R., et al.
Publicado: (2023)

Sex‐Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria
por: Spirito, Alessandro, et al.
Publicado: (2021)

Incorporation of Laboratory Test Biomarkers Into Dual Antiplatelet Therapy Score Improves Prediction of Ischemic and Bleeding Events in Post-percutaneous Coronary Intervention Patients
por: Sun, Chengming, et al.
Publicado: (2022)

A call for action in bleeding prevention
por: Gragnano, Felice, et al.
Publicado: (2019)

Risk of Postdischarge Bleeding From Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Among US Black and White Adults
por: Heindl, Brittain, et al.
Publicado: (2022)

The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis
por: Wang, Qi, et al.
Publicado: (2020)

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy
por: de Breet, C. P. D. M., et al.
Publicado: (2021)

Risk Factors for Severe Bleeding Complications in Glaucoma Surgery and the Role of Antiplatelet or Anticoagulant Agents
por: Lauermann, Peer, et al.
Publicado: (2022)

Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
por: Tung, Ying-Chang, et al.
Publicado: (2020)

Aspirin vs Clopidogrel: Antiplatelet Agent of Choice for Those With Recent Bleeding or at Risk for Gastrointestinal Bleed
por: Gosavi, Siddharth, et al.
Publicado: (2023)

Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke
por: Khazaal, Ossama, et al.
Publicado: (2021)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review
por: Tsigkas, Grigorios, et al.
Publicado: (2023)

Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
por: Gragnano, Felice, et al.
Publicado: (2022)

Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation
por: Voudris, Vassilis, et al.
Publicado: (2014)

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
por: Pivato, Carlo A., et al.
Publicado: (2022)

Patient perspectives of nuisance bleeding and adherence to dual antiplatelet therapy: a qualitative study
por: Pithara, Christalla, et al.
Publicado: (2020)

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
por: Natsuaki, Masahiro, et al.
Publicado: (2018)

Gastroscopy-related adverse cardiac events and bleeding complications among patients treated with coronary stents and dual antiplatelet therapy
por: Egholm, Gro, et al.
Publicado: (2016)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

RISK OF BLEEDING COMPLICATIONS IN PERCUTANEOUS BILIARY DRAINAGE: THE PARADOX OF THE NORMAL HEMOSTASIS
por: HOUGHTON, Eduardo Javier, et al.
Publicado: (2019)

Risk of bleeding following double balloon enteroscopy in patients on continued antiplatelet and/or anticoagulation therapy
por: Zaver, Himesh B., et al.
Publicado: (2021)

Bleeding Complications in Anticoagulated and/or Antiplatelet-Treated Patients at the Dental Office: A Retrospective Study
por: Martínez-Moreno, Esther, et al.
Publicado: (2021)

Regulation of Key Antiplatelet Pathways by Bioactive Compounds with Minimal Bleeding Risk
por: Fuentes, Eduardo, et al.
Publicado: (2021)

Correction to: One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
Publicado: (2022)

Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy
por: Yoo, Ah Young, et al.
Publicado: (2023)

Validation of Japanese Bleeding Risk Criteria in Patients After Percutaneous Coronary Intervention and Comparison With Contemporary Bleeding Risk Criteria
por: Shimizu, Takeshi, et al.
Publicado: (2022)

Percutaneous Tracheostomy in Patients at High Risk of Bleeding Complications: A Retrospective Single-center Experience
por: Sasane, Sachin P, et al.
Publicado: (2020)

Clinical Evaluation of Role of Dual Antiplatelet Therapy on Bleeding after Dental Extraction
por: Babaji, Prashant, et al.
Publicado: (2018)

Bleeding risk stratification in coronary artery surgery: the should-not-bleed score
por: Petricevic, Mirna, et al.
Publicado: (2021)

A New Score for Predicting Acute Gastrointestinal Bleeding in Patients Administered Oral Antiplatelet Drugs
por: Lv, Meina, et al.
Publicado: (2021)

Dual antiplatelet therapy with ticagrelor may increase the risk of all bleeding events in patients with minor strokes or high risk TIAs: a meta-analysis
por: Chen, Xi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n1s97b7e8jk24n2kdche74npr6